WO2007078271A3 - Lansoprazole orally disintegrating tablets - Google Patents
Lansoprazole orally disintegrating tablets Download PDFInfo
- Publication number
- WO2007078271A3 WO2007078271A3 PCT/US2005/046296 US2005046296W WO2007078271A3 WO 2007078271 A3 WO2007078271 A3 WO 2007078271A3 US 2005046296 W US2005046296 W US 2005046296W WO 2007078271 A3 WO2007078271 A3 WO 2007078271A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- orally disintegrating
- disintegrating tablets
- lansoprazole
- tablets
- lansoprazole orally
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Abstract
Priority Applications (10)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNA200580052347XA CN101340897A (en) | 2005-12-20 | 2005-12-20 | Orally disintegrating tablet of lansoprazole |
JP2008545558A JP2009519334A (en) | 2005-12-20 | 2005-12-20 | Lansoprazole Orally Disintegrating Tablet |
CA002630235A CA2630235A1 (en) | 2005-12-20 | 2005-12-20 | Lansoprazole orally disintegrating tablets |
PCT/US2005/046296 WO2007078271A2 (en) | 2005-12-20 | 2005-12-20 | Lansoprazole orally disintegrating tablets |
PCT/US2006/048961 WO2007075980A2 (en) | 2005-12-20 | 2006-12-20 | Lansoprazole orally disintegrating tablets |
EP06848925A EP1962844A2 (en) | 2005-12-20 | 2006-12-20 | Lansoprazole orally disintegrating tablets |
JP2008547591A JP2009524592A (en) | 2005-12-20 | 2006-12-20 | Lansoprazole Orally Disintegrating Tablet |
CA002633825A CA2633825A1 (en) | 2005-12-20 | 2006-12-20 | Lansoprazole orally disintegrating tablets |
IL191523A IL191523A0 (en) | 2005-12-20 | 2008-05-18 | Lansoprazole orally disintegrating tablets |
IL191923A IL191923A0 (en) | 2005-12-20 | 2008-06-03 | Lansoprazole orally disintegrating tablets |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/US2005/046296 WO2007078271A2 (en) | 2005-12-20 | 2005-12-20 | Lansoprazole orally disintegrating tablets |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2007078271A2 WO2007078271A2 (en) | 2007-07-12 |
WO2007078271A3 true WO2007078271A3 (en) | 2007-10-11 |
Family
ID=37672393
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2005/046296 WO2007078271A2 (en) | 2005-12-20 | 2005-12-20 | Lansoprazole orally disintegrating tablets |
Country Status (5)
Country | Link |
---|---|
JP (1) | JP2009519334A (en) |
CN (1) | CN101340897A (en) |
CA (1) | CA2630235A1 (en) |
IL (1) | IL191523A0 (en) |
WO (1) | WO2007078271A2 (en) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8497258B2 (en) | 2005-11-12 | 2013-07-30 | The Regents Of The University Of California | Viscous budesonide for the treatment of inflammatory diseases of the gastrointestinal tract |
UY31698A (en) * | 2008-03-11 | 2009-11-10 | Takeda Pharmaceutical | SOLID PREPARATION OF ORAL DISINTEGRATION |
CN101507718B (en) * | 2009-03-03 | 2011-05-04 | 张登科 | Sodium rabeprazole enteric-coated orally disintegrating tablets and preparation method thereof |
US20110097401A1 (en) | 2009-06-12 | 2011-04-28 | Meritage Pharma, Inc. | Methods for treating gastrointestinal disorders |
CN103402500A (en) * | 2010-12-27 | 2013-11-20 | 武田药品工业株式会社 | Orally disintegrating tablet |
CN102805737A (en) * | 2012-09-03 | 2012-12-05 | 海南中化联合制药工业股份有限公司 | Lansoprazole enteric oral disintegrating tablet and preparation method thereof |
JP6364406B2 (en) * | 2013-05-21 | 2018-07-25 | 武田薬品工業株式会社 | Orally disintegrating tablets |
EP3288556A4 (en) | 2015-04-29 | 2018-09-19 | Dexcel Pharma Technologies Ltd. | Orally disintegrating compositions |
US10076494B2 (en) | 2016-06-16 | 2018-09-18 | Dexcel Pharma Technologies Ltd. | Stable orally disintegrating pharmaceutical compositions |
JP7336187B2 (en) * | 2017-11-30 | 2023-08-31 | 日本ケミファ株式会社 | Particulate pharmaceutical composition having multilayer structure |
Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1999059544A2 (en) * | 1998-05-18 | 1999-11-25 | Takeda Chemical Industries, Ltd. | Orally disintegrable tablets |
US20040058018A1 (en) * | 1996-01-04 | 2004-03-25 | The Curators Of The University Of Missouri | Novel substituted benzimidazole dosage forms and method of using same |
WO2004066982A1 (en) * | 2003-01-31 | 2004-08-12 | Ranbaxy Laboratories Limited | Stable oral benzimidazole compositions and processes for their preparation |
WO2004091585A1 (en) * | 2003-04-16 | 2004-10-28 | Synthon B.V. | Orally disintegrating tablets |
US20040234594A1 (en) * | 1995-02-09 | 2004-11-25 | Per Johan Lundberg | Pharmaceutical formulation and process |
WO2005046634A2 (en) * | 2003-11-14 | 2005-05-26 | Siegfried Generics International Ag | Gastric juice-resistant form of administration |
WO2005105049A2 (en) * | 2004-04-19 | 2005-11-10 | Eurand Pharmaceuticals Limited | Orally disintegrating tablets and methods of manufacture |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2005092297A2 (en) * | 2004-03-03 | 2005-10-06 | Teva Pharmaceutical Industries Ltd. | A stable pharmaceutical composition comprising an acid labile drug |
-
2005
- 2005-12-20 CN CNA200580052347XA patent/CN101340897A/en active Pending
- 2005-12-20 JP JP2008545558A patent/JP2009519334A/en active Pending
- 2005-12-20 WO PCT/US2005/046296 patent/WO2007078271A2/en active Application Filing
- 2005-12-20 CA CA002630235A patent/CA2630235A1/en not_active Abandoned
-
2008
- 2008-05-18 IL IL191523A patent/IL191523A0/en unknown
Patent Citations (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20040234594A1 (en) * | 1995-02-09 | 2004-11-25 | Per Johan Lundberg | Pharmaceutical formulation and process |
US20040058018A1 (en) * | 1996-01-04 | 2004-03-25 | The Curators Of The University Of Missouri | Novel substituted benzimidazole dosage forms and method of using same |
WO1999059544A2 (en) * | 1998-05-18 | 1999-11-25 | Takeda Chemical Industries, Ltd. | Orally disintegrable tablets |
EP1736144A2 (en) * | 1998-05-18 | 2006-12-27 | Takeda Pharmaceutical Company Limited | Orally disintegrable tablets |
WO2004066982A1 (en) * | 2003-01-31 | 2004-08-12 | Ranbaxy Laboratories Limited | Stable oral benzimidazole compositions and processes for their preparation |
WO2004091585A1 (en) * | 2003-04-16 | 2004-10-28 | Synthon B.V. | Orally disintegrating tablets |
WO2005046634A2 (en) * | 2003-11-14 | 2005-05-26 | Siegfried Generics International Ag | Gastric juice-resistant form of administration |
WO2005105049A2 (en) * | 2004-04-19 | 2005-11-10 | Eurand Pharmaceuticals Limited | Orally disintegrating tablets and methods of manufacture |
Also Published As
Publication number | Publication date |
---|---|
CN101340897A (en) | 2009-01-07 |
WO2007078271A2 (en) | 2007-07-12 |
CA2630235A1 (en) | 2007-07-12 |
IL191523A0 (en) | 2008-12-29 |
JP2009519334A (en) | 2009-05-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2007078271A3 (en) | Lansoprazole orally disintegrating tablets | |
EG25188A (en) | Device for the packaging and dispensing of solid shaped bodies, especially oral tablets or/and capsules. | |
ZA200704661B (en) | Solid, orally appliance pharmaceutical administration forms containing rivaroxaban having modified release | |
WO2007075980A8 (en) | Lansoprazole orally disintegrating tablets | |
CA111398S (en) | Bottle | |
CA119221S (en) | Blister package | |
TNSN08071A1 (en) | Solid dosage forms of valsartan and amlodipine and method of making the same | |
WO2006138503A3 (en) | New regimens for oral monophasic contraceptives | |
TNSN08538A1 (en) | Solid dosage forms of valsartan, amlodipine and hydrochlorothiazide and method of making the same | |
BRPI0820997A2 (en) | Oral disintegration tablets comprising diphenhydramine. | |
GB0419849D0 (en) | Pharmaceutical combination | |
CA119774S (en) | Blister package | |
EP1961413A4 (en) | Rapidly disintegratable oral tablet | |
ZA200900673B (en) | 18-methyl-19-nor-androst-4-en-17, 17-spiroether (18-methyl-19-nor-20-spirox-4-en-3-one) and pharmaceutical preparations containing the same | |
CA118307S (en) | Pasta dispenser disk | |
HK1122218A1 (en) | Anticancer concomitant drug | |
WO2006046114A3 (en) | Osmotic dosage forms providing ascending drug release, and processes for their preparation | |
AP2343A (en) | Rapidly disintegrating taste-masked tablet. | |
ZA200408787B (en) | Pharmaceutical combination. | |
ES1056676Y (en) | ANTI-STRESS MOUTH. | |
GB2434893B8 (en) | Triangular Asynchronous Replication. | |
CA116344S (en) | Container for chewing gum | |
GB0417777D0 (en) | Pharmaceutical combination | |
GB0502561D0 (en) | The pill popper | |
ZA200501065B (en) | The availability of commodities. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
WWE | Wipo information: entry into national phase |
Ref document number: 200580052347.X Country of ref document: CN |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
WWE | Wipo information: entry into national phase |
Ref document number: 2630235 Country of ref document: CA |
|
WWE | Wipo information: entry into national phase |
Ref document number: 191523 Country of ref document: IL |
|
WWE | Wipo information: entry into national phase |
Ref document number: 4668/DELNP/2008 Country of ref document: IN |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2008545558 Country of ref document: JP |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 05854934 Country of ref document: EP Kind code of ref document: A2 |